An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases

Journal of Virology

Volumn 80, Issue 19, 2006, Pages 9619-9627

  Deszcz, Luiza ^a,b   Cencic, Regina ^a,c   Sousa, Carla ^a   Kuechler, Ernst ^a   Skern, Tim ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIVIRUS AGENT; ASPARTIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLMETHIONYL FLUOROMETHYL KETONE; CASPASE 9; INITIATION FACTOR 4G; INITIATION FACTOR 4GI; METHIONINE; OLIGOPEPTIDE; PROTEINASE; PROTEINASE INHIBITOR; PUROMYCIN; UNCLASSIFIED DRUG; VIRUS ENZYME;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS 16; HUMAN RHINOVIRUS 2; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CASPASES; CYSTEINE ENDOPEPTIDASES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PICORNAVIRIDAE; VIRAL PROTEINS; VIRUS REPLICATION;

EUKARYOTA; HUMAN RHINOVIRUS SP.; PICORNAVIRIDAE;

EID: 33748921764     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00612-06     Document Type: Article

References (36)

1. Aylward, R. B., R. W. Sutter, and D. L. Heymann. 2005. Policy. OPV cessation-the final step to a "polio-free" world. Science 310:625-626.
2. Belsham, G. J., and R. R. Jackson. 2000. Translation initiation on picornavirus RNA, p. 869-900. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control of gene expression, vol. 39. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
3. Berger, A., and I. Schechter. 1970. Mapping the active site of papain with the aid of peptide substrates and inhibitors. Phil. Trans. R. Soc. Lond. B 257: 249-264.
4. Carthy, C. M., B. Yanagawa, H. Luo, D. J. Granville, D. Yang, P. Cheung, C. Cheung, M. Esfandiarei, C. M. Rudin, C. B. Thompson, D. W. Hunt, and B. M. McManus. 2003. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology 313:147-157.
5. Crowder, S., and K. Kirkegaard. 2005. trans-Dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 37: 701-709.
6. Deszcz, L., J. Seipelt, E. Vassilieva, A. Roetzer, and E. Kuechler. 2004. Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase. FEBS Lett. 560:51-55.
7. 6a. Deszcz, L., E. Gaudernak, E. Kuechler, and J. Seipelt. 2005. Apoptotic events induced by human rhinovirus infection. J. Gen. Virol. 86:1379-1389.
8. Dougherty, W. G., and B. L. Semler. 1993. Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol. Rev. 57:781-822.
9. Dunn, B., and J. Kay. 1990. Viral proteinases: weakness in strength. Biochim. Biophys. Acta 1048:1-18.
10. Girard, S., T. Couderc, J. Destombes, D. Thiesson, F. Delpeyroux, and B. Blondel. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 73:6066-6072.
11. Glaser, W., and T. Skern. 2000. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. FEBS Lett. 480:151-155.
12. pro: relationship to self-cleavage and role of zinc. J. Virol. 77:5021-5025.
13. Gradi, A., Y. V. Svitkin, W. Sommergruber, H. Imataka, S. Morino, T. Skern, and N. Sonenberg. 2003. Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different. J. Virol. 77:5026-5029.
14. Hanecak, R., B. L. Semler, C. W. Anderson, and E. Wimmer. 1982. Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc. Natl. Acad. Sci. USA 79: 3973-3977.
15. Jelachich, M. L., and H. L. Lipton. 1996. Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J. Virol. 70:6856-6861.
16. Joachims, M., P. C. Van Breugel, and R. E. Lloyd. 1999. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 73:718-727.
17. Kerekatte, V., B. D. Keiper, C. Badorff, A. Cai, K. U. Knowlton, and R. E. Rhoads. 1999. Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J. Virol. 73:709-717.
18. Krausslich, H. G., and E. Wimmer. 1988. Viral proteinases. Annu. Rev. Biochem. 57:701-754.
19. Kuechler, E., J. Seipelt, H.-D. Liebig, and W. Sommergruber. 2002. Picornavirus proteinase-mediated shutoff of host cell translation: direct cleavage of a cellular initiation factor, p. 301-311. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
20. Liebig, H.-D., E. Ziegler, R. Yan, K. Hartmuth, H. Klump, H. Kowalski, D. Blaas, W. Sommergruber, L. Frasel, B. Lamphear, R. Rhoads, E. Kuechler, and T. Skern. 1993. Purification of two picornaviral 2A proteinases: interaction with eIF-4γ and influence on in vitro translation. Biochemistry 32: 7581-7588.
21. Livingston, D. J. 1997. In vitro and in vivo studies of ICE inhibitors. J. Cell Biochem. 64:19-26.
22. Matthews, D. A., P. S. Dragovich, S. E. Webber, S. A. Fuhrman, A. K. Patick, L. S. Zalman, T. F. Hendrickson, R. A. Love, T. J. Prins, J. T. Marakovits, R. Zhou, J. Tikhe, C. E. Ford, J. W. Meador, R. A. Ferre, E. L. Brown, S. L. Binford, M. A. Brothers, D. M. DeLisle, and S. T. Worland. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA 96:11000-11007.
23. Petersen, J. F., M. M. Cherney, H. D. Liebig, T. Skern, E. Kuechler, and M. N. James. 1999. The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. EMBO J. 18:5463-5475.
24. Reed, L. J., and H. Muench. 1938. A simple method of estimating 50 per cent end-points. Am. J. Hyg. 27:493-497.
25. Savolainen, C., S. Blomqvist, M. N. Mulders, and T. Hovi. 2002. Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J. Gen. Virol. 83:333-340.
26. Skern, T., B. Hampoelz, A. Guarné, I. Fita, E. Bergmann, J. Petersen, and M. N. G. James. 2002. Structure and function of picornavirus proteinases, p. 199-212. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
27. Skern, T., W. Sommergruber, D. Blaas, C. Pieler, and E. Kuechler. 1984. Relationship of human rhinovirus strain 2 and poliovirus as indicated by comparison of the polymerase gene regions. Virology 136:125-132.
28. Slee, E. A., H. Zhu, S. C. Chow, M. MacFarlane, D. W. Nicholson, and G. M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:21-24.
29. Sommergruber, W., H. Ahorn, H. Klump, J. Seipelt, A. Zoephel, F. Fessl, E. Krystek, D. Blaas, E. Kuechler, H. D. Liebig, and T. Skern. 1994. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4γ via a common recognition motif. Virology 198:741-745.
30. Sommergruber, W., H. Ahorn, A. Zophel, I. Maurer-Fogy, F. Fessl, G. Schnorrenberg, H. D. Liebig, D. Blaas, E. Kuechler, and T. Skern. 1992. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. J. Biol. Chem. 267:22639-22644.
31. Taimen, P., H. Berghall, R. Vainionpaa, and M. Kallajoki. 2004. NuMa and nuclear lamins are cleaved during viral infection-inhibition of caspase activity prevents cleavage and rescues HeLa cells from measles virus-induced but not from rhinovirus 1B-induced cell death. Virology 320:85-98.
32. Toyoda, H., M. J. Nicklin, M. G. Murray, C. W. Anderson, J. J. Dunn, F. W. Studier, and E. Wimmer. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761-770.
33. Wang, Q. M., R. B. Johnson, L. N. Jungheim, J. D. Cohen, and E. C. Villarreal. 1998. Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicrob. Agents Chemother. 42:916-920.
34. Wang, Q. M., R. B. Johnson, W. Sommergruber, and T. A. Shepherd. 1998. Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Arch. Biochem. Biophys. 356:12-18.
35. Wlodawer, A., and J. Vondrasek. 1998. Inhibitors of human immunodeficiency virus type 1 protease: a major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 27:249-284.
36. Zamora, M., W. E. Marissen, and R. E. Lloyd. 2002. Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells. J. Virol. 76:165-177.